CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia [Phase 1]
Summary
This clinical trial update reports on a phase 1 study evaluating RO5045337 in combination with cytarabine in patients with acute myeloid leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Myelogenous Leukemia, Acute | Phase 1 | Status: COMPLETED